Am J Transplant, Volume 17, Suppl 3 Archives - Page 35 of 181 - ATC Abstracts

2017 American Transplant Congress
Graft Loss from Anti-GBM Nephritis: A Rare Event in Alport Syndrome, Even with a Severe COL4A5/A4/A3 Mutation.
V. Gillion,¹ K. Dahan,² E. Goffin,¹ J.-P. Cosyns,³ M. Jadoul,¹ M. De Meyer,⁴ M. Mourad,⁴ Y. Pirson,¹ N. Kanaan.¹
¹Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; ²Génétique Humaine, Institut de Pathologie et de Génetique, Gosselies, Belgium; ³Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; ⁴Surgery and Abdominal Transplantation, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Background: Alport syndrome (AS) is caused by mutations in α3/α4/α5 (IV) collagen genes, whose severity determines the progression of AS. Post-transplant outcome is good, though…
2017 American Transplant Congress
Continuation of Immunosuppression Appears to Protect Against Allosensitization in Patients Listed for a Second Kidney Transplant.
S. Kuppachi,¹ M. Sanders,¹ R. Kalil,¹ Z. Stewart,² C. Thomas.¹
¹Internal Medicine, University of Iowa, Iowa City, IA; ²Transplant Surgery, University of Iowa, Iowa City, IA
Purpose: The current standard of practice after allograft loss is to discontinue immunosuppression (IS) to decrease complications related to prolonged exposure. There is a paucity…
2017 American Transplant Congress
De Novo Malignancy Occurrence After Kidney Transplantation in HLA-Sensitized Patients Treated with B-Cell Targeting Therapy.
L. Couzi,^1,2,3 P. Davis,¹ J. Visentin,^1,2,3 B. Taton,¹ G. Guidicelli,¹ H. Kaminski,^1,2,3 P. Merville,^1,2,3 T. Bachelet.⁴
¹CHU de Bordeaux, Bordeaux, France; ²Université de Bordeaux, Bordeaux, France; ³UMR CNRS 5164 Immunoconcept, Bordeaux, France; ⁴Clinique Saint-Augustin-CTMR, Bordeaux, France
Management of high risk transplantations in patients with preformed DSA still remains a dilemma. Many groups propose to increase the immunosuppression in these patients by…
2017 American Transplant Congress
Impact of Inflammatory Bowel Disease on Survival and Risk of Retransplantation of Primary Sclerosing Cholangitis Patients Following Liver Transplantation: UNOS Data Analysis.
O. Mousa,¹ N. Patel,¹ J. Corral,¹ D. Lee,² J. Nguyen,² K. Croome,² D. Harnois.²
¹Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL; ²Transplant, Mayo Clinic, Jacksonville, FL
Background: The impact of inflammatory bowel disease (IBD) on outcomes after liver transplantation (LT) for primary sclerosing cholangitis (PSC) has been inconclusive. Previous reports suggested…
2017 American Transplant Congress
Effective Thrombolytic Therapy of Hepatic Artery Thrombosis After Liver Transplantation – A Single-Center Experience.
M. Chen,¹ X. Lin,² W. Ju,¹ D. Wang,¹ Y. Ma,¹ L. Wu,¹ X. He,¹ G. Chen.¹
¹Organ Transplant Center, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China; ²Department of Thyroid and Breast Surgery, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
BACKGROUND: Hepatic artery thrombosis (HAT) is a common complication of liver transplantation which causes lots of graft loss. The anastomoses of hepatic artery requires delicate…
2017 American Transplant Congress
Recovery from Hypophosphatemia as a Predictor of Post-Operative Morbidity in Live Donor Hepatectomy.
O. Serrano,¹ D. Berglund,¹ V. Goduguchinta,¹ A. Reddy,¹ J. Menk,² D. Vock,³ V. Kirchner,¹ R. Kandaswamy,¹ A. Matas,¹ T. Pruett,¹ S. Chinnakotla.¹
¹Surgery, University of Minnesota, Minneapolis, MN; ²Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, Minneapolis, MN; ³Biostatistics, School of Public Health, Minneapolis, MN
OBJECTIVE: Live donor hepatectomy (LDH) is associated with significant post-operative hypophosphatemia (POH), which is associated with liver regeneration. We investigated whether the rate of recovery…
2017 American Transplant Congress
Waitlist and Post-Lung Transplant Mortality Vary by Diagnosis for a Given Lung Allocation Score.
H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.
JHU, Baltimore
The lung allocation score (LAS) is used to prioritize candidates based on predicted one-year waitlist mortality and post-transplant survival. Lung diagnosis is factored into LAS,…
2017 American Transplant Congress
Impact of Pediatric Lung Transplant on Quality of Life Outcomes.
T. Lazor,¹ H. Grasemann,^2,3,4 M. Solomon,^2,3,4 S. Anthony.^1,4,5,6
¹Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; ²Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada; ³Program in Physiology and Experimental Medicine, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; ⁴Transplant and Regenerative Medicine Centre, The Hospital for Sick Children, Toronto, ON, Canada; ⁵Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada; ⁶Canadian National Transplant Research Program, Toronto, Canada
Purpose: Considerable debate within the transplant community over the last decade has focused on survival benefits following lung transplant (LTx) in children. This discussion has…
2017 American Transplant Congress
Acute Renal Replacement Therapy in Pediatric Liver Transplantation: A Predictor of Increased Risk.
M. Wong,¹ R. Venick,² V. Agopian,¹ S. Ebaid,¹ S. McDiarmid,² A. Zarrinpar,¹ D. Farmer,¹ R. Busuttil,¹ F. Kaldas.¹
¹Surgery, UCLA, Los Angeles, CA; ²Pediatric Gastroenterology, UCLA, Los Angeles, CA
BackgroundAmong pediatric patients (≤18 yrs) awaiting liver transplantation (LT), limited data exist on the prognostic significance of acute (<90d) renal replacement therapy (RRT) prior to…
2017 American Transplant Congress
Review of UK-Wide Practice of Pancreas Transplantation: Donor Selection, Back-Bench Preparation & Implantation Technique.
H. Sharma,¹ S. Bhutani,³ D. Vandellen,² T. Campbell,² R. Pararajasingham,² B. Forgacs,² A. Tavakoli,² P. Friend,⁴ T. Augustine,² R. Dhanda.²
¹Multi Organ Transplant Unit, London Health Sciences Centre, London, ON, Canada; ²Kidney Pancreas Transplant Unit, Manchester Royal Infirmary, Manchester, United Kingdom; ³Multi Organ Transplant Unit, Toronto General Hospital, Toronto, Canada; ⁴Multi Organ Transplant Unit, Oxford Transplant Centre, Oxford, United Kingdom
Background: Experience of Centers for simultaneous pancreas and kidney (SPK) transplantation is not uniform. Variability in operative steps may explain inconsistent surgical outcomes.Methods: A web…